뇌실외배액 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global external ventricular drain market size is expected to reach USD 4.93 Billion in 2034 from USD 2.18 Billion in 2025, growing at a CAGR of 9.49% during 2026-2034.This market is witnessing steady growth as the prevalence of neurological disorders, traumatic brain injuries, hydrocephalus, and intracranial hemorrhage increases globally. External ventricular drains are widely used to monitor and manage intracranial pressure while providing controlled cerebrospinal fluid drainage in critical-care settings. Growing awareness regarding early intervention for neurological emergencies is encouraging hospitals to strengthen neurocritical-care capabilities. In addition, improvements in catheter design, drainage systems, infection-control features, and pressure-monitoring technologies are supporting product adoption. Increasing investments in advanced intensive-care infrastructure are also creating favorable opportunities for market expansion.

A major growth driver is the rising number of patients requiring neurosurgical intervention following strokes, head trauma, brain tumors, and other conditions associated with elevated intracranial pressure. Hospitals are increasingly emphasizing continuous neurological monitoring and timely cerebrospinal fluid management, which supports demand for external ventricular drainage systems. Technological developments aimed at reducing catheter-related infections are further strengthening adoption. The growing availability of specialized neurocritical-care units, particularly in emerging healthcare markets, is expected to improve access to these systems and broaden their utilization across tertiary and emergency-care facilities.

Future prospects remain positive as healthcare providers increasingly prioritize patient monitoring, infection prevention, and minimally invasive neurological procedures. Manufacturers are expected to focus on developing safer drainage systems with improved pressure-control mechanisms, enhanced monitoring capabilities, and easier handling. Expansion of hospital infrastructure in Asia Pacific, Latin America, and the Middle East is likely to create additional opportunities. Furthermore, increasing collaboration between medical device companies and healthcare institutions could accelerate product innovation. As neurological emergencies continue to require rapid and controlled intervention, demand for reliable ventricular drainage solutions is expected to remain strong over the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Application

• Traumatic Brain Injury
• Subarachnoid Hemorrhage
• Intracerebral Hemorrhage
• Other Non-Traumatic Hydrocephalus Conditions

By Patient Type

• Adult
• Pediatric

By End User

• Hospitals
• Others

COMPANIES PROFILED

• Spiegelberg GmbH & Co. KG, Medtronic, Sophysa, Natus Medical Incorporated, Neuromedex GmbH, Integra LifeSciences, Moller Medical GmbH, B. Braun SE, Fuji Systems, Johnson & Johnson MedTech, Raumedic AG, Wellong Instruments Co.Ltd., Dispomedica GmbH, Delta Surgical Limited, Ventura Medical Technologies, Ad-Tech Medical Instrument Corporation, Neurovent AG, Orsan Medical Technologies, Medprin Biotech GmbH, G. Surgiwear Ltd., HLL Lifecare Limited, Cook Medical, Vygon SA, Teleflex Incorporated, BD, Smiths Medical, ICU Medical Inc., Nipro Corporation

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Traumatic Brain Injury Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Subarachnoid Hemorrhage Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Intracerebral Hemorrhage Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Non-Traumatic Hydrocephalus Conditions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET: BY PATIENT TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Patient Type
• 5.2. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EXTERNAL VENTRICULAR DRAIN MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Application
  • 7.2.2 By Patient Type
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Application
  • 7.3.2 By Patient Type
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Application
  • 7.4.2 By Patient Type
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Application
  • 7.5.2 By Patient Type
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Application
  • 7.6.2 By Patient Type
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL EXTERNAL VENTRICULAR DRAIN INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Spiegelberg GmbH & Co. KG
  • 9.2.2 Medtronic
  • 9.2.3 Sophysa
  • 9.2.4 Natus Medical Incorporated
  • 9.2.5 Neuromedex GmbH
  • 9.2.6 Integra LifeSciences
  • 9.2.7 Moller Medical GmbH
  • 9.2.8 B. Braun SE
  • 9.2.9 Fuji Systems
  • 9.2.10 Johnson & Johnson MedTech
  • 9.2.11 Raumedic AG
  • 9.2.12 Wellong Instruments Co.Ltd
  • 9.2.13 Dispomedica GmbH
  • 9.2.14 Delta Surgical Limited
  • 9.2.15 Ventura Medical Technologies
  • 9.2.16 Ad-Tech Medical Instrument Corporation
  • 9.2.17 Neurovent AG
  • 9.2.18 Orsan Medical Technologies
  • 9.2.19 Medprin Biotech GmbH
  • 9.2.20 G. Surgiwear Ltd
  • 9.2.21 HLL Lifecare Limited
  • 9.2.22 Cook Medical
  • 9.2.23 Vygon SA
  • 9.2.24 Teleflex Incorporated
  • 9.2.25 BD
  • 9.2.26 Smiths Medical
  • 9.2.27 ICU Medical Inc
  • 9.2.28 Nipro Corporation